Cowen analyst Ken Cacciatore lowered the price target on Viatris (NASDAQ: VTRS) to $10.00 (from $15.00) while maintaining a Market ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

Viatris (VTRS) PT Lowered to $19 at BMO CapitalMarch 1, 2022 7:16 AM Biocon Biologics to Acquire Viatris' (VTRS) Biosimilars Assets for up to $3.335 billion in Stock and CashFebruary 28, 2022 8:42 AM Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and CashFebruary 28, 2022 8:41 AM Viatris Inc (VTRS) Reports Q4 Adjusted Net Earnings of $971MFebruary 28, 2022 6:09 AM Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results; Issues 2022 Financial Guidance; Completes Comprehensive Strategic Review; Unveils Plan to Reshape the Company for the FutureFebruary 28, 2022 6:00 AM